Hypoalbuminemia Is a Hepatocellular Carcinoma Independent Risk Factor for Tumor Progression in Low-Risk Bridge to Transplant Candidates by Kelley G. Núñez, Tyler Sandow, Jai Patel, Mina Hibino, Daniel Fort, Ari J. Cohen, Paul Thevenot

Get full text

Baseline Alpha-Fetoprotein, Alpha-Fetoprotein-L3, and Des-Gamma-Carboxy Prothrombin Biomarker Status in Bridge to Liver Transplant Outcomes for Hepatocellular Carcinoma by Kelley G. Núñez, Tyler Sandow, Daniel Fort, Jai Patel, Mina Hibino, Ian Carmody, Ari J. Cohen, Paul Thevenot

Get full text

Imaging Delay Following Liver-Directed Therapy Increases Progression Risk in Early- to Intermediate-Stage Hepatocellular Carcinoma by Jordin Stanneart, Kelley G. Nunez, Tyler Sandow, Juan Gimenez, Daniel Fort, Mina Hibino, Ari J. Cohen, Paul T. Thevenot

Get full text

Distinct Gene Expression Profiles in Viable Hepatocellular Carcinoma Treated With Liver-Directed Therapy by Kelley G. Núñez, Tyler Sandow, Meredith A. Lakey, Daniel Fort, Ari J. Cohen, Ari J. Cohen, Paul T. Thevenot

Get full text

Exosome Shedding Is Concordant with Objective Treatment Response Rate and Stratifies Time to Progression in Treatment Naïve, Non-Resectable Hepatocellular Carcinoma by Kelley G. Núñez, Dorota Wyczechowska, Mina Hibino, Tyler Sandow, Juan Gimenez, Ali R. Koksal, Yucel Aydin, Srikanta Dash, Ari J. Cohen, Paul T. Thevenot

Get full text

Interleukin-33 / Cyclin D1 imbalance in severe liver steatosis predicts susceptibility to ischemia reperfusion injury. by Kelley G Núñez, Anderson Frank, Janet Gonzalez-Rosario, Gretchen Galliano, Kim Bridle, Darrell Crawford, John Seal, Frank Abbruscato, Himanshu Vashistha, Paul T Thevenot, Ari J Cohen

Get full text